(MedPage Today) -- In patients with type 2 diabetes and heart failure, the use of sitagliptin (Januvia) was associated with greater risk of hospitalization for heart failure, a study based on insurance claims showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment